I.M.D. International Medical Devices S.p.A. (BIT:IMD)

BIT:IMD Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.35	8.34	4.55	3.01	6.74
Cash & Short-Term Investments	8.35	8.34	4.55	3.01	6.74
Cash Growth	0.18%	83.24%	51.38%	-55.38%	917.34%
Accounts Receivable	7.41	8.19	8.52	9.3	9.14
Other Receivables	1.81	2.06	4.72	2.16	1.82
Receivables	9.22	10.25	13.23	11.46	10.96
Inventory	12.45	13.96	15.5	16.3	14.14
Total Current Assets	30.31	32.83	33.53	30.96	32.08
Property, Plant & Equipment	0.57	0.62	1.11	1.27	1.19
Long-Term Investments	0.2	0.28	0	0	0
Goodwill	0.08	0.09	-	0.21	0.43
Other Intangible Assets	0.12	0.09	0.1	0.13	0.06
Long-Term Deferred Charges	1.09	1.2	1.16	0	0.01
Other Long-Term Assets	0.52	0.63	0.28	0.22	0.19
Total Assets	32.89	35.74	36.19	32.8	33.96

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.01	6.12	7.01	9.09	8.92
Accrued Expenses	0.33	0.33	0.32	0.36	0.47
Current Portion of Long-Term Debt	0.18	0.17	1.58	1.36	0.27
Current Income Taxes Payable	0	-	0.05	0.18	0.57
Other Current Liabilities	2.07	3.54	2.43	3.17	2.64
Total Current Liabilities	7.6	10.17	11.39	14.16	12.87
Long-Term Debt	0.06	0.23	0	1.29	0.68
Long-Term Unearned Revenue	0.58	0.33	0.02	0.03	0.06
Pension & Post-Retirement Benefits	0.01	0.01	0.01	0.23	0.23
Other Long-Term Liabilities	1.67	1.68	1.54	1.66	7.81
Total Liabilities	9.91	12.42	12.96	17.36	21.64

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4	4	4	2.38	2.38
Additional Paid-In Capital	4.28	4.28	4.28	0.47	0.47
Retained Earnings	14.22	14.55	13.36	11.56	8.64
Treasury Stock	-0.1	-0.1	-0.1	-0.52	-0.52
Comprehensive Income & Other	0.58	0.58	-	-	-0.02
Total Common Equity	22.98	23.31	21.54	13.9	10.96
Minority Interest	-	-	1.69	1.54	1.37
Shareholders' Equity	22.98	23.31	23.23	15.43	12.33
Total Liabilities & Equity	32.89	35.74	36.19	32.8	33.96

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.24	0.4	1.58	2.65	0.95
Net Cash (Debt)	8.11	7.93	2.97	0.36	5.78
Net Cash Growth	2.25%	167.26%	731.67%	-93.83%	1010.87%
Net Cash Per Share	0.47	0.46	0.17	-	-
Filing Date Shares Outstanding	17.32	17.32	17.32	-	-
Total Common Shares Outstanding	17.32	17.32	17.32	-	-
Working Capital	22.71	22.66	22.14	16.8	19.21
Book Value Per Share	1.33	1.35	1.24	-	-
Tangible Book Value	22.78	23.14	21.44	13.55	10.47
Tangible Book Value Per Share	1.31	1.34	1.24	-	-
Land	0.04	0.04	0.54	0.54	0.53
Machinery	2.11	1.98	1.93	1.85	1.81

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 16, 2026

Data Sources Report a data error